The mitogen-induced lymphocyte proliferative response and its sensitivity to in vitro (lO-'O-lO-h Ml dexamethasone (DEX) administration were investigated in 12 severely depressed patients and 13 healthy controls. Patients with major depressive disorder exhibited no impairment of lectin-induced blastogenesis, but a significantly weaker suppressive effect of in vitro DEX on 1.0 pg/ml phytohemagglutinin A-induced proliferation.
Summary
The mitogen-induced lymphocyte proliferative response and its sensitivity to in vitro (lO-'O-lO-h Ml dexamethasone (DEX) administration were investigated in 12 severely depressed patients and 13 healthy controls. Patients with major depressive disorder exhibited no impairment of lectin-induced blastogenesis, but a significantly weaker suppressive effect of in vitro DEX on 1.0 pg/ml phytohemagglutinin A-induced proliferation.
The inhibitory potency of in vitro DEX was inversely correlated with in vivo adrenal cortical hormone levels at 4.00 p.m. These effects were not observed with pokeweed mitogenand concanavalin A-stimulated cells. There were no correlations with age, weight, sex or severity of depression.
These results do not support the hypothesis of a primarily impaired cell-mediated immunity, but might be indicative of reduced glucocorticoid receptor sensitivity in major depressive disorder.
Introduction
In recent years, knowledge about the interactions between the brain, behavior and immunity has expanded rapidly (Ader et al., 1990) . One well-studied mechanism of nervous system influ-ence on the immune system is regulation via adrenal cortical hormones.
Both the experience of stressful life events and the syndrome of depression have been associated with alterations in circulating concentrations of glucocorticoids, as well as alterations in immune function (Calabrese et al., 1987; Irwin et al., 1987) .
During acute depressive illness approximately 50% of patients were shown to have increased hypothalamic-pituitary-adrenal (HPA) axis activity, e.g., excess cortisol production and resistance to dexamethasone suppression (Carroll et al., 1968; Linkowski et al., 1985) . Nevertheless, they fail to display clinical signs of Cushing's syndrome.
There might be a simple explanation for this phenomenon, such as a different duration and magnitude of hypercortisolism as compared to Cushing's syndrome. Since a variety of hormones are reported to be resistant to glucocorticoid-induced changes, e.g., adrenocorticotropic hormone (ACTH), P-endorphin and prolactin (Fang et al., 1981; Rupprecht et al., 1987 Rupprecht et al., , 1988 , a glucocorticoid receptor dysfunction in major depressive disorder might be hypothesized.
This again should have some effects on immune system integrity, since peripheral blood mononuclear cells possess glucocorticoid receptors and are sensitive to glucocorticoids (Cupps and Fauci, 1982) .
Usually in vivo pharmacologic doses of glucocorticoids inhibit antigen-and mitogen-induced T lymphocyte proliferation and lymphokine production. In contrast, B lymphocytes are known to be sensitive to the suppressive effects of glucocorticoids only in the early activation phase of the cell cycle (Cupps and Fauci, 1982; Bowen and Fauci, 1984) .
Most frequently, the mitogen response assay was used to determine the capacity of T and B lymphocytes to respond to antigens, i.e., the integrity of cell-mediated immunity. The commonly used lectins concanavalin A (Con A) and phytohemagglutinin A (PHA) are known to stimulate T lymphocytes quite selectively, whereas pokeweed mitogen (PWM) induces an accessory cell-dependent B lymphocyte proliferation (Rosenberg and Lipsky, 1979; Cupps and Fauci, 1982) . Some groups have reported a significantly lower response to these lectins in lymphocytes of depressed patients compared to various control groups (Schleifer et al., 1984; Calabrese et al., 1986; Kronfol et al., 1986; Cosyns et al., 1989 ).
Other investigators
were not able to replicate these findings (Albrecht et al., 1985; Darko et al., 1989; Schleifer et al., 1989) 
Methods

Patients
Twelve subjects (mean age + SD: 48.7 t_ 15.1 years; mean body weight f SD: 72.5 + 13.4 kg), admitted to the psychiatric clinic of the University of Wiirzburg with severe unipolar major depressive disorder or bipolar depression (according to DSM-IIIR) and 13 non-hospitalized healthy controls, closely matched for age, sex and weight (mean age + SD: 47.4 f 6.4 years; mean body weight i SD: 69.2 + 8.6 kg) were studied. Four female depressives and the matched controls were tested during the midluteal phase of the cycle, the other females were postmenopausal.
All subjects were carefully screened for nutritional status and prevalence of medical illness, as well as alcohol or nicotine abuse and stressful life events that might influence pituitary-adrenal or immune system function, by medical history, physical examination and routine laboratory investigation.
All patients were drug-free for at least 4 days prior to investigation, and seven patients for more than 3 weeks. DSM-IIIR (American Psychiatric Association, 1987) diagnoses were made independently by two psychiatrists, who were blind to laboratory investigations. Severity of depression was assessed on the day of laboratory investigation using the 21-item Hamilton Rating Scale for Depression (HRS-D; Hamilton, 1960) . Controls had no history of psychiatric disorder, nor had they relatives with a psychiatric illness. They were free of any medication and their HRS-D scores were below 5.
Written informed consent was obtained from all subjects prior to the investigation.
This study was approved by the ethical committee of the University of Wiirzburg.
Assays
All subjects were admitted to a sleep laboratory unit at least 1 h prior to blood sampling. For determination of hormonal values and lymphocyte proliferation parameters 50 ml venous blood was collected at 4.00 p.m. into plastic tubes containing EDTA.
Preparation of cells
Peripheral blood mononuclear cells (PBMC) were prepared from EDTA blood under sterile conditions by sodium metrizoate-Ficoll density gradient centrifugation as described previously (Rupprecht et al., 1990) . Briefly, cells were washed twice in phosphate-buffered saline (PBS) at 100 x g for 10 min and incubated for 60 min at 37°C followed by a third washing procedure. The final cell count was performed with a Coulter counter (Model S5, Coulter Electronics Ltd, England). The viability of cells exceeded 95%, as judged from their ability to exclude trypan blue (Pappenheimer, 1917) . Contamination by granulocytes and monocytes was always less than 8%.
Cell culture
PBMC were suspended at a concentration of 2.5 x 104/well in culture medium (see Chemicals) and incubated in triplicate in 96-well microtiter plates (0.2 ml/well; NUNC, Sweden) for 60 h to evaluate Con A-and PHA-generated T cell proliferation and for 132 h to evaluate PWM-generated accessory cell-dependent B cell proliferation in a sterile, humidified atmosphere (5% CO,/95% air). To determine lectin dose-response curves, Con A and PWM were added at final concentrations of 0.5, 1.0, 5.0, 10.0, 20.0, 40.0 and 50.0 pg/ml, PHA at 0.1, 0.5, 1.0, 2.5, 5.0, 10.0 and 20.0 pg/ml.
Eventually, lectin-induced DNA synthesis in lymphocytes was analyzed at one optimal and one non-optimal concentration of each lectin ( Raff and Findling, 1989 ). The lower detection limit was 1.5 pmol/l, and the intra-and interassay coefficients of variation were 3% and 6.8%, respectively.
Cortisol was measured by a direct radioimmunoassay (RIA) (Stalla et al., 1981) . The lower detection limit was 25 nmol/l, and the intra-and interassay coefficients of variation were 5% and 9%, respectively. 
Chemicals
Results
Cell ('iability Under the culture conditions of the lymphocyte proliferation assays, the mean cell viabilities at the time of harvest (day 3 and day 5) were 97.0% + 1.3% and 94.8% f 2.5%, respectively. Cortisol and ACTH values were not significantly correlated in patients with major depressive disorder (r = 0.387, P = 0.24, n = 12), but nearly reached statistical significance in controls (r = 0.520, P < 0.07, n = 13). Due to the increased number of cases it reached significance in the whole cohort of subjects (r = 0.45 1, P < 0.03, II = 25). with the non-optimal PHA concentration (1.0 pg/ml) was significantly associated with ACTH values in depressed patients (r = -0.66, P < 0.04).
Descriptir'e statistics
Lectin-induced lymphocyte blastogenesis
Sensitirity of lymphocyte blastogenesis to in ritro added dexamethasone
In vitro added DEX produced a dose-dependent suppression of spontaneous, PHA-(Figs. 1, 2) and Con A-induced lymphocyte proliferative responses (not shown) in patients and healthy controls. In vitro DEX administration exhibited no suppressive effect on PWM-stimulated blastogenesis in either group (Fig. 3) .
In all subjects serum cortisol levels at 4.00 p.m. were significantly associated with the inhibitory potency of in vitro DEX on 1.0 pg/ml PHA- all assays were performed in triplicate). After covarying out serum cortisol levels, the differences between healthy controls (n = 13) and depressive patients (n = 12) were statistically significant (P < 0.05; see Results for details).
stimulated cells (Table 3) . ACTH levels were only correlated with the inhibition of PHA-induced proliferation by lo-"-lo-" mol/l DEX (Table  3) . The results with 10.0 pg/ml PHA-stimulated cells are shown in Table 3 .
No significant correlations could be observed between levels of adrenal cortical hormones and DEX-induced inhibition of cells stimulated with optimal or non-optimal concentrations of Con A and PWM.
Since the in vitro PHA-stimulated lymphocyte proliferative response was correlated with the in vivo hormone levels (Table 31, all assays were performed in triplicate). The differences between healthy controls (n = 13) and depressive patients (n = 12) were statistically not significant. all assays were performed in triplicate). The differences between healthy controls (n = 13) and depressive patients (n = 12) were statistically not significant.
weigh this influence statistically. Therefore, individuals' in vitro lymphocyte proliferation was adjusted for their in vivo cortisol levels (ANCOVA). This revealed that 1.0 pg/ml PHA-stimulated lymphocytes of depressed patients exhibited a significantly weaker suppression of blastogenesis after in vitro addition of 1O-8 mol/l (F = 4.49, PC 0.04), lo-' mol/l (F= 6.09, P < 0.03) and lo-" mol/l DEX (F = 6.61, P < 0.02). The same results could be obtained after serum ACTH levels were covaried out (lo-" mol/l: F = 5.11, P < 0.04; lo-' mol/l: F = 3.99, P< 0.05; lo-" mol/l DEX: F = 5.52, P < 0.03). Only a non-significant trend (P = 0.1) could be seen with 10.0 pug/ml PHA-stimulated lymphocytes. No significant differences in DEX sensitivity of PWM-and Con A-stimulated lymphocytes could be detected between the two groups, even after covarying out the influence of in vivo hormone values.
Discussion
In accordance
with Albrecht et al. (1985) , Darko et al. (1989) and Schleifer et al. (1989) we were not able to corroborate previous findings of primarily impaired cell-mediated immunity in depressed patients by means of the lymphocyte transformation assay (Schleifer et al., 1984; Calabrese et al., 1986; Kronfol et al., 1986; Cosyns et al., 1989) . There were no differences in PWM-, PHA-or Con A-induced proliferative responses between patients with major depressive disorder and healthy controls. Schleifer et al. (1989) attributed impaired lectin-induced lymphocyte blastogenesis to factors such as age or severity of depression.
However, in accordance with other groups (Albrecht et al., 1985; Kronfol et al., 1986; Cosyns et al., 1989) we were not able to confirm such an association. Moreover, in contrast to Schleifer et al. (19891, we could not observe a significant contribution of severity of depression, as assessed by the 21-item HRS-D, or of several independent variables, such as gender, age or weight.
These discrepancies might be due to our relatively homogeneous and small group of severely depressed patients, as well as to differences in the methodology applied. Previous studies took blood samples in the morning hours, when the level of cortisol reaches its circadian peak (Ritchie et al., 1983) . Glucocorticoid receptors are supposed to be down-regulated in the morning hours and up-regulated in the evening (Rupprecht et al., 1990) . Therefore, glucocorticoid-induced effects might be more evident when blood samples are taken in the afternoon hours. This also indicates that single-point measurements of circulating hormones might not exactly reflect the blood concentrations over the previous several hours, which primarily determine receptor sensitivity.
The circadian variation of lymphocyte subpopulations is well established, as well as their differ-ent sensitivity to glucocorticoids (Ritchie et al., 1983) . Moreover, stimulation of T lymphocyte subpopulations is thought to depend partly on the lectin and on the concentrations used (Dwyer and Johnson, 1981) . Therefore, the circadian rhythm of T cell subsets in the peripheral blood and their different sensitivity to glucocorticoids might be a reason for the discrepant results after stimulation with the T cell mitogens PHA and Con A.
Data in previous work (with the exception of Darko et al., 1989) This supports previous findings from our and other laboratories that the glucocorticoid receptor is under autoregulatory control in humans (Lowy et al., 1988; Rupprecht et al., 1990) . Moreover, after covarying out the influence of in vivo hormone levels, PHA-stimulated lymphocytes of depressed patients exhibited an impaired sensitivity to pharmacological as well as physiological concentrations of in vitro glucocorticoids.
These results are partly in contrast to those of Lowy et al. (19881, who also described a weaker DEX-induced suppression of lymphocyte blastogenesis, but only after stimulation with Con A. This discrepancy might be mainly attributed to the above-mentioned methodological differences (e.g., time of blood sampling and concentrations of lectins), as well as to differences in selection criteria of patients (e.g., dexamethasone suppressors and non-suppressors).
Our data suggest that in depressed patients immune system integrity could usually be maintained by adaptation to the endogenous hypercortisolemia. But this fragile new homeostasis might be difficult to maintain if additional disturbances occur (e.g., pharmacologically induced or physiological shifts of in vivo hormonal balance). This might further support the hypothesis of a glucocorticoid receptor dysfunction in patients with major depressive disorder, since a variety of hormones are reported to be resistant to glucocorticoid-induced changes during the acute phase of the disease, as well (Fang et al., 1981; Rupprecht et al., 1987 Rupprecht et al., , 1988 . Moreover, some recent reports have described that antidepressants elicit an increase of glucocorticoid receptor mRNA and immunoreactivity in neuronal cell cultures and in the locus coeruleus of rats (Pepin et al., 1989; Kitayama et al., 1988) .
In conclusion, the elucidation of the exact mechanism of impaired glucocorticoid sensitivity (i.e., abnormalities in glucocorticoid receptor activation, translocation, genomic interaction, expression of proteins, etc.) may yield insights into the pathophysiology of major depressive disorder. Therefore, further analysis of glucocorticoid receptor function (e.g., by means of in vivo and in vitro challenge studies) is needed to more clearly delineate the relationship among the hypothesized impaired receptor plasticity, derangement of HPA axis activity and major depressive disorder.
